Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: EMCURE and BSE: 544210 (ISIN INE168P01015).
It has a market capitalisation of ₹33,493 crore, a last close of ₹1,767 on 2026-10-19, a one-year return of 31.1%.
Valuation: a price-to-earnings ratio of 33.12x, a price-to-book ratio of 6.77x, a dividend yield of 0.2%.
Profitability: return on equity of 19.7%, return on capital employed of 25.4%, an operating margin of 20.5%.
Balance sheet and ownership: debt-to-equity of 0.24x, promoter holding of 77.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 33,493 |
| Last close | ₹1,767 |
| P/E (TTM) | 33.12x |
| P/B | 6.77x |
| Dividend yield | 0.2% |
| ROE (FY) | 19.7% |
| ROCE (FY) | 25.4% |
| Operating margin (TTM) | 20.5% |
| Debt / equity | 0.24x |
| Promoter holding | 77.8% |
| 1-year return | 31.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means